Xenon Pharmaceuticals Stock (NASDAQ: XENE) stock price, news, charts, stock research, profile.
Open | $41.160 |
Close | $39.500 |
Volume / Avg. | 325.554K / 362.146K |
Day Range | 39.240 - 41.160 |
52 Wk Range | 27.985 - 50.990 |
Market Cap | $2.980B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 3.67% |
Days to Cover | 8.55 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Xenon Pharmaceuticals (NASDAQ: XENE) through any online brokerage.
There are no as such competitors for Xenon Pharmaceuticals.
The latest price target for Xenon Pharmaceuticals (NASDAQ: XENE) was reported by Needham on Friday, April 12, 2024. The analyst firm set a price target for 62.00 expecting XENE to rise to within 12 months (a possible 56.96% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Xenon Pharmaceuticals (NASDAQ: XENE) is $39.5 last updated April 24, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Xenon Pharmaceuticals.
Xenon Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Xenon Pharmaceuticals.
Xenon Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.